Breztri vs Wixela

Breztri vs Wixela

What to choose Breztri or Wixela

Breztri and Wixela are inhalers both of Control type. Breztri and Wixela are both brand inhalers. Breztri is manufactured by pharmaceutical company AstraZeneca, while Wixela is manufactured by Viatris. The main substances of Breztri are Budesonide and Formoterol. The available dosages for Breztri are 160 mcg / 4,8 mcg. The main substances of Wixela are Fluticasone and Salmeterol. The available dosage for Wixela is 250/50.

The current cost for Breztri is approximately $556.34 while average cost for Wixela is approximately $240, said Valentin Myers, an Assistant Professor at the University of Alaska-Fairbanks and a Medical Director at a clinic that uses Breztri and Wixela.

GENERIC PROAIR from $35.88 per inhaler Buy Now

Breztri and Wixela Comparison

Wixela vs Breztri
Breztri Wixela
Type: Control Control
Manufacturer: AstraZeneca Viatris
Substance: Budesonide + Formoterol Fluticasone + Salmeterol
Dosage: 160 mcg / 4,8 mcg 250/50
Avg Price: $556.34 $240

GENERIC SYMBICORT from $53.54 per inhaler Buy Now